![]() |
市场调查报告书
商品编码
1625236
2030 年微藻类市场预测:按类型、类别、形式、等级、应用、分销管道和地区进行的全球分析Microalgae Market Forecasts to 2030 - Global Analysis By Type (Spirulina, Chlorella, Haematococcus Pluvialis, Dunaliella Salina and Other Types), Category (Organic and Inorganic), Form, Grade, Application, Distribution Channel and By Geography |
根据 Stratistics MRC 的数据,2024 年全球微藻类市场规模为 127 亿美元,预计到 2030 年将达到 207 亿美元,预测期内复合年增长率为 8.4%。
微藻类被认为是在淡水和海洋栖息地中发现的最小的光合作用动物。这些生物是生态系统的基础,产生氧气并在水生食物网中占据重要地位。它营养丰富且易于补充,可作为可再生生质燃料、营养补充剂、化妆品和药物成分。微藻类可以固定二氧化碳,有助于缓解气候变化,对于环境和工业应用至关重要。
据美国能源局(DOE) 称,美国微藻类的潜在生物质产量估计为每年 1.52 亿吨(无灰干重)。
增强健康意识
消费者健康意识的提高是微藻类市场的主要驱动力。微藻类作为保健补充剂和机能性食品很受欢迎,因为它们富含蛋白质、维生素和Omega-3脂肪酸等必需营养素。人们对植物性饮食和天然食品成分的日益偏好进一步支持了这一趋势。随着人们对微藻类健康益处的认识不断增强,预计各行业对这些产品的需求将会增加。
生产成本高
高生产成本仍是微藻类市场的主要限制因素。微藻类的培养和加工需要先进的技术、受控的环境和大量的能源输入,从而导致营运成本增加。这些成本往往转嫁给消费者,限制了市场渗透,特别是在价格敏感地区。透过技术进步和规模经济降低生产成本对于克服这项挑战和扩大市场至关重要。
药品和化妆品领域的扩张
微藻类在药品和化妆品中的广泛应用为市场成长提供了利润丰厚的机会。微藻类衍生的化合物,如抗氧化剂和生物活性胜肽,由于其抗衰老和癒合特性,越来越多地用于护肤产品和治疗配方中。这些产业对天然和永续成分不断增长的需求正在推动对基于微藻类的解决方案的进一步创新和投资,为市场扩张创造新的途径。
缺乏标准化
微藻类培育、加工和品质评估缺乏标准化对市场构成重大威胁。产品品质的变化可能会削弱消费者的信心并阻碍监管部门的核准,特别是对于食品和药品应用。建立标准化实践和认证对于确保一致性、提高产品可靠性以及促进整个产业广泛采用微藻类衍生产品至关重要。
随着消费者越来越重视健康和增强免疫力的产品,COVID-19 大流行对微藻类市场产生了正面影响。在此期间,对含有微藻类的营养补充品的需求激增。此外,传统食品供应链的中断凸显了微藻类等替代蛋白质来源的潜力。这些因素共同加速了微藻类类产品在各领域的采用。
食品和饮料行业预计将在预测期内成为最大的行业。
由于越来越多地使用微藻类作为保健食品、食品和饮料以及营养补充剂中的功能成分,食品和饮料领域预计将主导市场。其高营养价值使其成为满足消费者对天然植物来源产品需求的理想选择。将微藻类纳入主流食品应用的技术创新将进一步推动这一领域的成长。
预计小球藻细分市场在预测期内的复合年增长率最高。
小球藻细分市场预计将表现出最高的复合年增长率,因为它具有广泛的健康益处,例如解毒、免疫支持和改善消化。此外,高蛋白质含量使其成为素食的首选。小球藻在营养保健品、化妆品和饲料中的使用越来越多,强调了它在多种应用中的多功能性和快速成长潜力。
在预测期内,由于其成熟的水产养殖业和藻类产品的高消费量,预计亚太地区将占据最大的市场占有率。中国、日本和印度等国家正在透过对机能性食品、营养保健品和化妆品的强劲需求推动区域成长。此外,政府促进永续农业的措施进一步支持该地区的市场扩张。
由于消费者对微藻类相关健康益处的认识不断提高,预计北美地区在预测期内将出现最高的成长率。该地区对植物性蛋白质和天然成分的强劲需求正在推动食品、饮料和营养补充剂的创新。此外,文化技术的进步也促进了北美市场的快速成长。
According to Stratistics MRC, the Global Microalgae Market is accounted for $12.7 billion in 2024 and is expected to reach $20.7 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Microalgae are considered the smallest, photosynthetic animals in freshwater and marine habitats. These organisms are basics to ecological systems, capable of producing oxygen and holding a basic position in the aquatic food webs. They are highly nutrient-rich and they can easily be replenished as a raw material for renewable biofuels, dietary supplements, cosmetics, and pharmaceuticals. Capable of carbon dioxide fixation, microalgae contribute to climate change mitigation, making them vital for environmental and industrial applications.
According to the U.S. Department of Energy (DOE), the total microalgae biomass production potential in the United States is estimated at 152 million tons per year (ash-free dry weight).
Increasing health consciousness
The rising health consciousness among consumers has significantly driven the microalgae market. Microalgae are rich in essential nutrients, including proteins, vitamins, and omega-3 fatty acids, making them a popular choice for health supplements and functional foods. This trend is further supported by the growing preference for plant-based diets and natural food ingredients. As awareness of the health benefits of microalgae continues to grow, demand for these products is expected to rise across various industries.
High production costs
High production costs remain a significant restraint for the microalgae market. Cultivating and processing microalgae require advanced technologies, controlled environments, and substantial energy inputs, leading to increased operational expenses. These costs are often passed on to consumers, limiting market penetration, particularly in price-sensitive regions. Reducing production costs through technological advancements and economies of scale is essential to overcoming this challenge and expanding the market.
Expansion in pharmaceuticals and cosmetics
The growing application of microalgae in pharmaceuticals and cosmetics presents a lucrative opportunity for market growth. Microalgae-derived compounds, such as antioxidants and bioactive peptides, are increasingly used in skincare products and therapeutic formulations due to their anti-aging and healing properties. The rising demand for natural and sustainable ingredients in these sectors further drives innovation and investment in microalgae-based solutions, creating new avenues for market expansion.
Lack of standardization
The lack of standardization in microalgae cultivation, processing, and quality assessment poses a significant threat to the market. Variability in product quality can undermine consumer trust and hinder regulatory approvals, especially in food and pharmaceutical applications. Establishing standardized practices and certifications is critical to ensuring consistency, enhancing product credibility, and fostering wider adoption of microalgae-derived products across industries.
The COVID-19 pandemic positively impacted the microalgae market as consumers increasingly prioritized health and immunity-boosting products. The demand for dietary supplements containing microalgae surged during this period. Additionally, disruptions in traditional food supply chains highlighted the potential of alternative protein sources like microalgae. These factors collectively accelerated the adoption of microalgae-based products across various sectors.
The food & beverages segment is expected to be the largest during the forecast period
The food & beverages segment is expected to dominate the market due to the increasing use of microalgae as a functional ingredient in health foods, beverages, and dietary supplements. Its high nutritional value makes it an ideal choice for addressing consumer demand for natural and plant-based products. The segment's growth is further driven by innovations in incorporating microalgae into mainstream food applications.
The chlorella segment is expected to have the highest CAGR during the forecast period
The chlorella segment is expected to witness the highest CAGR due to its extensive health benefits, including detoxification, immune support, and improved digestion. Its high protein content also makes it a preferred choice for vegan diets. The increasing use of chlorella in dietary supplements, cosmetics, and animal feed highlights its versatility and potential for rapid growth across multiple applications.
Over the forecast period, the Asia Pacific region is anticipated to account for the largest market share due to its well-established aquaculture industry and high consumption of algae-based products. Countries like China, Japan, and India drive regional growth through their strong demand for functional foods, dietary supplements, and cosmetics. Additionally, government initiatives promoting sustainable agriculture further support market expansion in this region.
The North America region is anticipated to register the highest growth rate over the forecast period owing to increasing consumer awareness about health benefits associated with microalgae. The region's robust demand for plant-based proteins and natural ingredients drives innovation in food & beverages as well as nutraceuticals. Moreover, advancements in cultivation technologies contribute to the rapid growth of this market in North America.
Key players in the market
Some of the key players in Microalgae Market include DIC Corporation, Cyanotech Corporation, Corbion N.V., AlgaEnergy S.A., Cellana Inc., Euglena Co., Ltd., Algaecytes, Parry Nutraceuticals, Allmicroalgae, Kuehnle AgroSystems, Algatech, Algarithm, Sunrise Nutrachem Group Co., Ltd., BASF SE, Koninklijke DSM N.V., Solabia Group, TerraVia Holdings, Inc. and Roquette Freres.
In August 2024, Euglena Co., Ltd. signs with Petronas Research Sdn. Bhd. a subsidiary of Petroliam Nasional Berhad (hereafter "Petronas Research") that have entered into a Joint Development Agreement on August 21st , 2024 to implement a joint research with a mission to materialize the future large-scale commercial production of microalgae oil for SAF and other biofuels.
In July 2024, Parry Nutraceuticals, a division of EID Parry (I) Ltd, based in Chennai, has become a world leader and expert in micro-algal technology. Parry is the only micro-algal innovator in the world producing all three microalgae-spirulina, haematococcus (astaxanthin), and chlorella. The company works with ecologically sustainable cultivation practices that help preserve nutrients for optimum absorption.
In March 2024, Kuehnle AgroSystems ("KAS"), a leading microalgal innovation and production company, today announced that it has raised a $3 million Series A2 funding round led by S2G Ventures. The funding will accelerate the commercialization of KAS's pioneering method for producing natural astaxanthin from microalgae, a key component in sustainable aquaculture systems as well as a clinically proven human nutraceutical.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.